These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


261 related items for PubMed ID: 24552352

  • 1. Assessment of the adjuvant effect of tacrolimus in the management of pemphigus vulgaris: A randomized controlled trial.
    Dastgheib L, Sadati MS, Baghernejhad M.
    J Dermatolog Treat; 2015 Feb; 26(1):90-3. PubMed ID: 24552352
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
    Olszewska M, Kolacinska-Strasz Z, Sulej J, Labecka H, Cwikla J, Natorska U, Blaszczyk M.
    Am J Clin Dermatol; 2007 Feb; 8(2):85-92. PubMed ID: 17428113
    [Abstract] [Full Text] [Related]

  • 3. Role of thiopurine methyltransferase activity in the safety and efficacy of azathioprine in the treatment of pemphigus vulgaris.
    Firooz A, Ghandi N, Hallaji Z, Chams-Davatchi C, Valikhani M, Karbakhsh Davari M.
    Arch Dermatol; 2008 Sep; 144(9):1143-7. PubMed ID: 18794458
    [Abstract] [Full Text] [Related]

  • 4. Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris.
    Chams-Davatchi C, Esmaili N, Daneshpazhooh M, Valikhani M, Balighi K, Hallaji Z, Barzegari M, Akhyani M, Ghodsi SZ, Seirafi H, Nazemi MJ, Mortazavi H, Mirshams-Shahshahani M.
    J Am Acad Dermatol; 2007 Oct; 57(4):622-8. PubMed ID: 17583373
    [Abstract] [Full Text] [Related]

  • 5. Mycophenolate is effective in the treatment of pemphigus vulgaris.
    Enk AH, Knop J.
    Arch Dermatol; 1999 Jan; 135(1):54-6. PubMed ID: 9923781
    [Abstract] [Full Text] [Related]

  • 6. Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial.
    Mentink LF, Mackenzie MW, Tóth GG, Laseur M, Lambert FP, Veeger NJ, Cianchini G, Pavlovic MD, Jonkman MF.
    Arch Dermatol; 2006 May; 142(5):570-6. PubMed ID: 16702494
    [Abstract] [Full Text] [Related]

  • 7. Assessment of the therapeutic benefit of oral prednisolone and common adjuvant therapy in stage II of randomized controlled trial study for management of pemphigus vulgaris.
    Esmaili N, Chams-Davatchi C, Valikhani M, Daneshpazhooh M, Toosi S, Karimi A, Mortazavi H.
    Arch Iran Med; 2014 Sep; 17(9):626-8. PubMed ID: 25204479
    [Abstract] [Full Text] [Related]

  • 8. Outcome of pemphigus vulgaris.
    Kavusi S, Daneshpazhooh M, Farahani F, Abedini R, Lajevardi V, Chams-Davatchi C.
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):580-4. PubMed ID: 18194237
    [Abstract] [Full Text] [Related]

  • 9. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus.
    Beissert S, Werfel T, Frieling U, Böhm M, Sticherling M, Stadler R, Zillikens D, Rzany B, Hunzelmann N, Meurer M, Gollnick H, Ruzicka T, Pillekamp H, Junghans V, Luger TA.
    Arch Dermatol; 2006 Nov; 142(11):1447-54. PubMed ID: 17116835
    [Abstract] [Full Text] [Related]

  • 10. Treatment of pemphigus: a local experience.
    Akhtar SJ, Hasan MU.
    J Pak Med Assoc; 1998 Oct; 48(10):300-4. PubMed ID: 10087750
    [Abstract] [Full Text] [Related]

  • 11. Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy.
    Manousou P, Samonakis D, Cholongitas E, Patch D, O'Beirne J, Dhillon AP, Rolles K, McCormick A, Hayes P, Burroughs AK.
    Liver Transpl; 2009 Dec; 15(12):1783-91. PubMed ID: 19938143
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Randomized double blind trial of prednisolone and azathioprine, vs. prednisolone and placebo, in the treatment of pemphigus vulgaris.
    Chams-Davatchi C, Mortazavizadeh A, Daneshpazhooh M, Davatchi F, Balighi K, Esmaili N, Akhyani M, Hallaji Z, Seirafi H, Mortazavi H.
    J Eur Acad Dermatol Venereol; 2013 Oct; 27(10):1285-92. PubMed ID: 23062214
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Recalcitrant pemphigus vulgaris responding to systemic tacrolimus.
    Büsing V, Kern JS, Bruckner-Tuderman L, Hofmann SC.
    Dermatology; 2010 Oct; 221(2):122-6. PubMed ID: 20587990
    [Abstract] [Full Text] [Related]

  • 18. Epidemiology of pemphigus in the western region of Turkey: retrospective analysis of 87 patients.
    Bozdag K, Bilgin İ.
    Cutan Ocul Toxicol; 2012 Dec; 31(4):280-5. PubMed ID: 22309241
    [Abstract] [Full Text] [Related]

  • 19. [Prolonged complete clinical remission in patients with severe pemphigus vulgaris after cycles of intravenous cyclophosphamide].
    España Alonso A, Panizo C, Fernández S, Marquina M, Pretel M, Aguado L, Sánchez-Ibarrola A.
    Actas Dermosifiliogr; 2009 Mar; 100(2):113-20. PubMed ID: 19445875
    [Abstract] [Full Text] [Related]

  • 20. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
    Beissert S, Werfel T, Frieling U, Böhm M, Sticherling M, Stadler R, Zillikens D, Rzany B, Hunzelmann N, Meurer M, Gollnick H, Ruzicka T, Pillekamp H, Junghans V, Bonsmann G, Luger TA.
    Arch Dermatol; 2007 Dec; 143(12):1536-42. PubMed ID: 18087004
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.